In developing our programs, we follow the three principles below.
- Identifying proteins involved in neurodegenerative diseases: each program identifies a specific protein or combinations of proteins central to the development and progression of a neurodegenerative disease
- Shaping immune responses: AFFITOPEs® are designed to provide substantial specific and long-lasting immune responses against the pathological protein
- Optimizing clinical response: each product candidate is optimized to enhance immunogenicity and clinical response
We are in the process of preparing for the next stage of clinical trials with our leading SAIT candidates. Please check back later for more information.
You can view our completed clinical trials via the external links below.